Graham G. Walmsley, Director at Akero Therapeutics, holds 1.41M shares in Olema Pharmaceuticals (Ticker: OLMA), holds 802.17K shares in Akero Therapeutics (Ticker: AKRO), holds 3.16M shares in ALX Oncology Holdings (Ticker: ALXO). Most recently, Graham G. Walmsley Sold ― shares of Olema Pharmaceuticals on Dec 17, 2024 for an estimated value of 9.46M.
What is the percentage of profitable transactions made by Graham G. Walmsley?
The percentage of profitable transactions made by Graham G. Walmsley is 55%.
What is the average return per transaction made by Graham G. Walmsley?
The average return per transaction made by Graham G. Walmsley is -0.40%.
What stocks does Graham G. Walmsley hold?
Graham G. Walmsley holds: AKRO, ALXO, OLMA stocks.
What was Graham G. Walmsley’s latest transaction?
Graham G. Walmsley latest transaction was an Informative Sell of $9.46M.
What was Graham G. Walmsley's most profitable transaction?
Graham G. Walmsley’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
What is Graham G. Walmsley's role in Akero Therapeutics?
Graham G. Walmsley's role in Akero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.